India raises hospital procedure rates, boosting major healthcare stocks across Fortis, Apollo, Max, Narayana, and the sector.

• Macquarie expects 5‑30% rate hikes in cardiology, neurology, oncology, orthopedics, and labeling meaningful revision after fifteen.
• Fortis leads gain, up 7%, while Narayana climbs 5%; Apollo and Max rise modestly today.
• Analysts project mid‑single‑digit EBITDA growth for Max and Apollo, assuming a high‑teens rate increase in 2025.